期刊文献+

抗病毒治疗后HIV感染者NKT样细胞衰老和体外增殖研究

Study on senescence and proliferation of NKT like cells in HIV infected patients after antiviral therapy
下载PDF
导出
摘要 目的:研究高效抗逆转录病毒治疗(Highly active antiretroviral therapy,HAART)后NKT样细胞衰老和体外增殖情况。方法:选取未接受HAART治疗、接受HAART治疗的HIV感染者以及健康人的外周血细胞,利用流式细胞仪检测接受HAARRT治疗前后的HIV感染者NKT样细胞CD57的表达情况以及体外增殖能力。结果:HIV感染者在HAART治疗前NKT样细胞的百分数显著低于健康对照组(P<0.01),HAART治疗后恢复(P<0.05);HAART治疗前NKT样细胞CD57的表达明显高于健康对照组(P<0.01),HAART治疗后恢复(P<0.05);HAART治疗前NKT样细胞体外增殖能力明显低于健康对照组,HAART治疗后有所恢复。结论:经过HAART治疗后,HIV感染者NKT样细胞的数量、CD57表达以及体外增殖能力有所恢复。 Objective:To better understand the changes of the NKT like cells after HIV infection and HAART treatment.Methods:Peripheral blood from HIV-infected individuals,HAART-treatment AIDS patients and healthy controls were collected,the expression of CD57 and the proliferation ability of NKT like cells before and after HAART were analyzed by flow cytometry.Results:We found that the percentage of NKT like cells before HAART was significantly lower than the healthy controls(P〈0.01),and recovered after HAART treatment(P〈0.05);the aging of NKT like cells was significantly higher before HAART compared with health individuals(P 0.01),and recovered after HAART treatment(P〈0.05) the proliferation was significantly lower in vitro before HAART compared with healthy controls,and partial recovered after HAART.Conclusion:After HAART treatment,the number of NKT like cells,CD57 expression and the proliferation ability of HIV infected patients were restored.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2016年第9期1354-1356,共3页 Chinese Journal of Immunology
基金 十二五科技重大专项(2014ZX10001002-001-004) 基础临床紧密结合平台项目(医大发字[2013]5号)
关键词 HIV NKT样细胞 HAART Human immunoddficiency virus NKT like cells Highly active antiretroviral therapy
  • 相关文献

参考文献3

二级参考文献86

  • 1姜拥军,尚红,张子宁,耿文清,刁莹莹,代娣,韩晓旭,张旻,王亚男,刘静,王树祥,苏艳丽,王琪.中国HIV/AIDS患者NK细胞及NKT细胞变化的检测[J].中华微生物学和免疫学杂志,2005,25(1):52-55. 被引量:15
  • 2Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immuno12007; 25:297-336.
  • 3Kronenberg M. TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes. Annu Rev Immunol 2005; 23:877-900.
  • 4Barral DC, Brenner MB. CD 1 antigen presentation: how it works. Nat Rev Immuno12007; 7:929-941.
  • 5Brigl M, Brenner MB. CDI: antigen presentation and T cell function. Annu Rev Immuno12004; 22:817-890.
  • 6Zhou D, Mattner J, Cantu C 3rd, et al. Lysosomal glycosphingo-lipid recognition by NKT cells. Science 2004; 306:1786-1789.
  • 7Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 2003; 198:173-181.
  • 8Kinjo Y, WuD, Kim G, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434:520-525.
  • 9Kinjo Y, Tupin E, Wu D, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7:978-986.
  • 10Fischer K, Scotet E, Niemeyer M, et al. Mycobacterial phospha- tidylinositol mannoside is a natural antigen for CD 1 d-restricted T cells. Proc NatlAcadSci USA 2004; 101:10685-10690.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部